These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38700008)

  • 1. CSL112 (Apolipoprotein A-I [Human]) Reduces the Elevation in Neutrophil-to-Lymphocyte Ratio Induced by Acute Myocardial Infarction.
    Kingwell BA; Duffy D; Clementi R; Velkoska E; Feaster J; Gibson CM
    J Am Heart Assoc; 2024 May; 13(9):e033541. PubMed ID: 38700008
    [No Abstract]   [Full Text] [Related]  

  • 2. The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction.
    Gibson CM; Kerneis M; Yee MK; Daaboul Y; Korjian S; Mehr AP; Tricoci P; Alexander JH; Kastelein JJP; Mehran R; Bode C; Lewis BS; Mehta R; Duffy D; Feaster J; Halabi M; Angiolillo DJ; Duerschmied D; Ophuis TO; Merkely B
    Am Heart J; 2019 Feb; 208():81-90. PubMed ID: 30580130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
    Gibson CM; Duffy D; Korjian S; Bahit MC; Chi G; Alexander JH; Lincoff AM; Heise M; Tricoci P; Deckelbaum LI; Mears SJ; Nicolau JC; Lopes RD; Merkely B; Lewis BS; Cornel JH; Trebacz J; Parkhomenko A; Libby P; Sacks FM; Povsic TJ; Bonaca M; Goodman SG; Bhatt DL; Tendera M; Steg PG; Ridker PM; Aylward P; Kastelein JJP; Bode C; Mahaffey KW; Nicholls SJ; Pocock SJ; Mehran R; Harrington RA;
    N Engl J Med; 2024 May; 390(17):1560-1571. PubMed ID: 38587254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil to lymphocyte ratio in acute ST-segment elevation myocardial infarction.
    Erkol A; Oduncu V; Turan B; Kiliçgedik A; Karabay CY; Akgün T; Güler A; Pala S; Kirma C
    Am J Med Sci; 2014 Jul; 348(1):37-42. PubMed ID: 24172233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behaviour of the neutrophil to lymphocyte ratio in young subjects with acute myocardial infarction.
    Caimi G; Lo Presti R; Canino B; Ferrera E; Hopps E
    Clin Hemorheol Microcirc; 2016; 62(3):239-47. PubMed ID: 26444599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-lymphocyte ratio as an independent predictor of left main and/or three-vessel disease in patients with non-ST-segment elevation myocardial infarction.
    Misumida N; Kobayashi A; Saeed M; Fox JT; Kanei Y
    Cardiovasc Revasc Med; 2015 Sep; 16(6):331-5. PubMed ID: 26051172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Neutrophil-Lymphocyte Ratio in Patients With ST-Elevated Acute Myocardial Infarction.
    Gazi E; Bayram B; Gazi S; Temiz A; Kirilmaz B; Altun B; Barutcu A
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):155-9. PubMed ID: 23754837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Blood Cell Subtypes Are Associated with a Greater Long-Term Risk of Death after Acute Myocardial Infarction.
    Shiyovich A; Gilutz H; Plakht Y
    Tex Heart Inst J; 2017 Jun; 44(3):176-188. PubMed ID: 28761398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neutrophil lymphocyte ratio in patients with ST segment elevation myocardial infarction.
    Balta S; Demırkol S; Arslan Z; Demır M; Ozturk C
    Eur Rev Med Pharmacol Sci; 2014; 18(1):141. PubMed ID: 24452955
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çiçek G; Açıkgoz SK; Bozbay M; Altay S; Uğur M; Uluganyan M; Uyarel H
    Angiology; 2015 May; 66(5):441-7. PubMed ID: 24834932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study.
    Kaya MG; Akpek M; Lam YY; Yarlioglues M; Celik T; Gunebakmaz O; Duran M; Ulucan S; Keser A; Oguzhan A; Gibson MC
    Int J Cardiol; 2013 Sep; 168(2):1154-9. PubMed ID: 23219132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio for Prognosis.
    Eyüboğlu M
    Angiology; 2016 Feb; 67(2):195. PubMed ID: 26124492
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutrophil-to-lymphocyte Ratio and Its Relation with Markers of Inflammation and Myocardial Necrosis in Patients with Acute Coronary Syndrome.
    Tahto E; Jadric R; Pojskic L; Kicic E
    Med Arch; 2017 Oct; 71(5):312-315. PubMed ID: 29284896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Neutrophil to Lymphocyte Ratio for In-hospital Mortality in Elderly Patients with Acute Myocardial Infarction.
    Guo TM; Cheng B; Ke L; Guan SM; Qi BL; Li WZ; Yang B
    Curr Med Sci; 2018 Apr; 38(2):354-359. PubMed ID: 30074197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post-Myocardial Infarction.
    Didichenko SA; Velkoska E; Navdaev AV; Greene BH; Lorkowski SW; Duffy D; Mears SJ; Wright SD; Gibson CM; Smith JD; Kingwell BA
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):855-869. PubMed ID: 36994730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neutrophil-to-lymphocyte ratio predicts persistent coronary no-flow after wire insertion in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Celik IE; Kilic A; Ocek AH
    Clinics (Sao Paulo); 2015 Jan; 70(1):34-40. PubMed ID: 25672427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Park JJ; Jang HJ; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Cho GY; Chae IH; Choi DJ
    Am J Cardiol; 2013 Mar; 111(5):636-42. PubMed ID: 23273716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of neutrophil and neutrophil/lymphocyte ratio in coronary collateral developed patients with acute coronary syndrome.
    Mansiroglu AK; Sincer I; Gunes Y
    Rev Assoc Med Bras (1992); 2020 Jul; 66(7):954-959. PubMed ID: 32844936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Chen X; Meng Y; Shao M; Zhang T; Han L; Zhang W; Zhang H; Hai H; Li G
    Med Sci Monit; 2020 Jan; 26():e919300. PubMed ID: 31949123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.